Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Reneo Pharmaceuticals (RPHM)
NASDAQ:RPHM
Holding RPHM?
Track your performance easily
See the Price Targets and Ratings of:
RPHM Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RPHM Stock 12 Month Forecast
There Are No Analyst Ratings for RPHM In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
RPHM Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$1.5
Hold
-91.76%
Downside
Reiterated
05/14/24
Mitchell Kapoor's Hold Rating on Reneo Pharmaceuticals Amid OnKure Merger and Oncology Pipeline Potential
Leerink Partners
$1
Hold
-94.51%
Downside
Reiterated
05/07/24
Maintaining Hold on Reneo Pharmaceuticals Amidst Strategic Uncertainties and Pipeline Setbacks
Bank of America Securities
$1.2
Sell
-93.41%
Downside
Reiterated
03/28/24
Sell Rating on Reneo Pharmaceuticals Amid Strategic Uncertainty and Reduced Price Target
Jefferies
$17→$1.8
Hold
-90.11%
Downside
Downgraded
12/15/23
Reneo Pharmaceuticals just downgraded at Jefferies, here's whyReneo Pharmaceuticals just downgraded at Jefferies, here's why
Ladenburg Thalmann & Co.
―
Hold
―
Downgraded
12/14/23
Reneo Pharmaceuticals just downgraded at Ladenburg, here's whyReneo Pharmaceuticals just downgraded at Ladenburg, here's why
Piper Sandler
$25→$4
Hold
-78.02%
Downside
Downgraded
12/14/23
Piper Sandler downgrades Reneo Pharmaceuticals (RPHM) to NeutralPiper Sandler analyst Yasmeen Rahimi downgraded Reneo Pharmaceuticals (NASDAQ: RPHM) from Overweight to Neutral with a price target of $4.00 (from $25.00).
Robert W. Baird
$3
Hold
-83.52%
Downside
Downgraded
12/14/23
Analysts Offer Insights on Healthcare Companies: Rain Therapeutics (NASDAQ: RAIN), Reneo Pharmaceuticals (NASDAQ: RPHM) and Bicycle Therapeutics (NASDAQ: BCYC)
Best Analysts Covering Reneo Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy RPHM and Sell After:
1 Month
xxx
Success Rate
1/4 ratings generated profit
Average Return
-8.63%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 25.00% of your transactions generating a profit, with an average return of -8.63% per trade.
3 Months
xxx
Success Rate
2/4 ratings generated profit
Average Return
-21.02%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -21.02% per trade.
1 Year
Success Rate
0/4 ratings generated profit
Average Return
-52.00%
reiterated a sell rating 8 months ago
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -52.00% per trade.
2 Years
xxx
Success Rate
0/4 ratings generated profit
Average Return
-52.00%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -52.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RPHM Analyst Recommendation Trends
Rating
Oct 23
Nov 23
Dec 23
Mar 24
May 24
Strong Buy
0
0
0
0
0
Buy
9
10
9
3
0
Hold
0
0
8
9
11
Sell
0
0
0
0
0
Strong Sell
0
0
1
2
2
total
9
10
18
14
13
Each month's total comprises the sum of three months' worth of ratings.
RPHM Stock Forecast FAQ
What is RPHM’s average 12-month price target, according to analysts?
Currently, no data Available
What is RPHM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for RPHM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RPHM a Buy, Sell or Hold?
Currently, no data Available
What is Reneo Pharmaceuticals’s price target?
Currently, no data Available
What do analysts say about Reneo Pharmaceuticals?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of RPHM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.